Edition:
United States

CellaVision AB (CEVI.ST)

CEVI.ST on Stockholm Stock Exchange

148.00SEK
11:06am EST
Change (% chg)

0.50kr (+0.34%)
Prev Close
147.50kr
Open
146.25kr
Day's High
148.75kr
Day's Low
144.75kr
Volume
46,170
Avg. Vol
85,792
52-wk High
188.00kr
52-wk Low
79.75kr

Summary

Name Age Since Current Position

Soren Mellstig

66 2016 Independent Chairman of the Board

Zlatko Rihter

47 2015 President, Chief Executive Officer

Magnus Blixt

51 2015 Chief Financial Officer

Mattias Lundin

49 2015 Vice President Global Sales

Peter Wilson

50 Vice President Global Marketing

Maria Morin

43 2015 Vice President Human Resources & Corporate Communications

Magnus Johnsson

42 2016 Vice President Quality

Magnus Lindeberg

42 2016 Vice President Supply & Sourcing

Adam Morell

41 2015 Vice President Innovation & Engineering

Jeppe Bransdstrup

43 2016 Vice President Business Development

Christer Fahraeus

52 1998 Director

Asa Hedin

55 2015 Independent Director

Roger Johanson

58 2011 Independent Director

Torbjorn Kronander

60 2007 Independent Director

Anna Malm Bernsten

56 2010 Independent Director

Niklas Prager

47 2014 Independent Director

Biographies

Name Description

Soren Mellstig

Mr. Soren Mellstig has been Independent Chairman of the Board at CellaVision AB since May 4, 2016. He holds Master of Business Administration degree. He is Chairman of Trelleborg AB (publ), Ellevio AB, Impilo AB and Textilia AB, as well as Board Member of Ferrosan MD A/S. He previously held management positions at Akzo Nobel, and served as CFO and Vice President of Incentive, CFO, President and finally President and CEO of Gambro 2000-2006.

Zlatko Rihter

Mr. Zlatko Rihter has been President and Chief Executive Officer of CellaVision AB since January 1, 2015. He has held various managing positions within business development, sales, marketing, research and IT. He has over 20 years of experience from the medtech industry. He most recently worked for Origio A/S as Executive Vice President and was responsible for global sales and marketing. He also worked for ArjoHuntleigh (Getinge) and Gambro, where he was President for EMEA Sales (2012-2013), among others. He is Member of the Board of ETAC AB and Malmo FF. He holds a Master of Science degree in Mechanical Engineering from Lunds Tekniska Hogskola (part of Lunds Universitet) and studied Economics at Lunds Universitet.

Magnus Blixt

Mr. Magnus Blixt has served as Chief Financial Officer of CellaVision AB since May 2, 2013. He holds Master of Business Administration degree. He has experience of developing small and medium sized companies focusing on business performance and process improvements, within the SKF Group and Rotaform AB, among others. He most recently held the position as Business Demand Manager at SKF AB.

Mattias Lundin

Mr. Mattias Lundin has been Vice President Global Sales at CellaVision AB since 2015. He has many years experience from the medtech industry, holding leading positions in sales and marketing. His most recent position was as VP Commercial for international and mature markets at ArjoHuntleigh, a company within Getinge group. He holds a diploma in Business Administration & Marketing Management.

Peter Wilson

Mr. Peter Wilson serves as Vice President Global Marketing at CellaVision AB. He previously served as Head of CellaVisions subsidiary in North America from 2012 till 2014. He has been employed by the Company from 2000. He has many years of experience from global launching of new technologies and new products. He previously worked for Foss, among others. He holds a Master of Science degree in Chemistry.

Maria Morin

Ms. Maria Morin serves as Vice President Human Resources & Corporate Communications at CellaVision AB. She holds a Bachelor of Science degree in Human Resources and a Bachelor of Science degree in Economics and Business Administration. She has been employed at the Company since 2009. She has experience from various positions and companies within the field of human resources. Her most recent position was at Gambro AB.

Magnus Johnsson

Mr. Magnus Johnsson has been Vice President Quality at CellaVision AB since 2016. He previously was employed at the Company from 2000 till 2008. He has more than 15 years experience in med. tech industry from companies such as ArjoHuntleigh and Xellia Pharmaceuticals. His most recent position was at Xellia Pharmaceuticals. He holds M.Sc. Chemistry, B Sc. Information Systems.

Magnus Lindeberg

Mr. Magnus Lindeberg has been Vice President Supply & Sourcing at CellaVision AB since 2016. He has more than 17 years experience in the medical device industry in various senior positions in the supply chain and production included Gambro. He comes from a position as Manager Materials Supply Baxter (formerly Gambro AB). He holds M.Sc. in Mechanical Engineering.

Adam Morell

Mr. Adam Morell has been Vice President Innovation & Engineering at CellaVision AB since 2015. He previously served as Development Manager at CellaVision AB until 2011. He was employed by the Company from 2001 to 2003 and then from 2006 to 2011. He also served at Agellis Group AB. He holds a Master of Science Degree in Engineering Physics, a Licentiate of Engineering in Mathematics and a Bachelor of Science degree in Medicine.

Jeppe Bransdstrup

Mr. Jeppe Bransdstrup has been Vice President Business Development at CellaVision AB since 2016. He has many years of experience in business development and acquisitions in the life sciences. He most recently served as Senior Acquisition Manager at Novozymes in Copenhagen. He holds M.Sc. in Finance.

Christer Fahraeus

Mr. Christer Fahraeus has been Member of the Board of Directors of CellaVision AB since June 1998. Previously he was Chief Executive Officer and Member of the Board of the Company. He joined the Board in 1994. He is founder of the Company. His former positions include Chief Executive Officer of Anoto Group AB and Agellis Group AB. He is founder of Anoto Group AB, Precise Biometrics AB, Agellis Group AB and Flatfrog Laboratories AB, among others. He is Chief Executive Officer of EQL Pharma AB and Chairman of the Board of Longboat laboratoriesof, Respiratorius AB and Flatfrog Laboratories AB. He is also Member of the Boards of EQL Pharma AB, Lunds universitets innovationssystem AB, Faro Capital AB and Reccan AB. Mr. Fahraeus holds a Master of Science degree in Bioengineering and a Bachelor of Science degree in Mathematics from Lunds Universitet. He also holds a honoris causa Doctorate in Philosophy from Lunds Universitet.

Asa Hedin

Ms. Asa Hedin has been Independent Director at CellaVision AB since May 6, 2015. She is also Member of the Board of Nolato AB, Immunovia AB, Fingerprint AB and Tobii AB. She previously held leading positions at Elekta AB being responsible for strategy, marketing and training, moreover leading positions at Siemens Healthcare and Gambro. She holds Master of Business Administration degree.

Roger Johanson

Mr. Roger Johanson has served as Independent Member of the Board of Directors of CellaVision AB since 2011. He serves as Partner at Caram Alternative Investments AB and is former Head of Venture Capital & Direct Investments at Skandia Liv. His former positions include Chief Executive Officer and President at Medicarb AB and management positions at Boehringer Mannheim Scandinavica AB, DAKO A/S and Becton Dickinson AB. He is Member of the Boards of Skandia Fastighets AB. He holds a Master of Science degree in Chemical Engineering.

Torbjorn Kronander

Dr. Torbjorn Kronander has served as Independent Member of the Board of Directors of CellaVision AB since 2007. He is President and CEO of Sectra AB, as well as founder of Sectras’ medical division and co-founder of the research center, CMIV (Center for Medical Image Science and Visualization) in Linkoping. He is also Member of the Board of Sectra AB and Shannon AB. He holds a Doctorate of Technology and a Master of Business Administration degree. He is Honorary Doctor of Medicine and Member of the Board in IVA.

Anna Malm Bernsten

Ms. Anna Malm Bernsten has served as Independent Member of the Board of Directors of CellaVision AB since April 29, 2010. She is Chief Executive Officer of Bernsten Konsult AB. She is Chairman of the Board of Medivir AB and Bjorn Axen Institute AB, as well as Member of the Board of Pagengruppen AB. She was Chairman of the Board of Oatly AB during 2016. Her former positions include Chief Executive Officer and President of Carmeda AB and management positions at Pharmacia & Upjohn and GE Healthcare Life Sciences. She holds a Master of Science degree in Chemical Engineering.

Niklas Prager

Mr. Niklas Prager has been Independent Member of the Board of Directors of CellaVision AB since May 7, 2014. He was President and CEO of Medivir AB during 2016. His former positions include CEO of Envirotainer AB, Qbtech AB and Pfizer AB. He is Member of the Board of Qbtech AB and Adero AB. He holds Master of Business Administration degree.